Search filters

Filters
Clear All

Phase

  • 54
  • 61
  • 2
  • 53
  • 1
  • 51
  • 11
  • 670
  • 926
  • 606
  • 5
  • 39
  • 886

Found 930 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

40-75 years
All genders
The goal of this research is to test a novel centralized care coordinator program to assist patients with psoriatic disease in lowering their risk of cardiovascular disease through the application of standard of care approaches to improving modifiable cardiovascular risk factors.
 OCEANIC-STROKE: Phase 3 study to investigate the efficacy and safety of the oral FXIa inhibitor asundexian (BAY 2433334) compared with placebo in participants after an acute noncardioembolic ischemic stroke or high-risk TIA - 2023-28
18-100 years
All genders
Phase 3
The main purpose of this study is to learn whether asundexian works better than placebo at reducing ischemic strokes in participants who recently had a non-cardioembolic ischemic stroke or temporary stroke-like symptoms when given in addition to standard antiplatelet therapy.  The study treatment asundexian is a new type of anticoagulant …
18 years and older
All genders
Phase 2
The purpose of the study is to assess whether an investigational drug, called XmAb20717, has any effects on certain types of cancers and if it is safe and well tolerated.
 Dosing of LT4 (DOT4)
65-100 years
All genders
The purpose of this study is to find the effects of taking different doses of the thyroid medication levothyroxine in older people who already take levothyroxine for hypothyroidism. Older people are more likely to have problems when their dose of levothyroxine is too strong. Allowing lower doses of levothyroxine would …
99 years and younger
All genders
The primary objective of our proposed trial will be to test the hypothesis that a prolonged, unresolved skin inflammation coupled with musculoskeletal power-doppler ultrasound (MSKPDUS) abnormalities driven by IL-23 increase the risk for transition into PsA and that an intervention that targets one of these pivotal molecules (i.e., Guselkumab) will: …
 Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
50-80 years
Accepts healthy volunteer
All genders
This is a Phase II, double-blind, sham controlled, randomized, crossover, multisite clinical trial investigating the effectiveness of transcranial direct current stimulation (tDCS) coupled with naming and spelling therapy (NASP) to improve language in people with primary progressive aphasia (PPA).
99 years and younger
All genders
A Phase 1/2a dose escalation and expansion study of mirdametinib in combination with BGB-3245 in adult participants with advanced metastatic or unresectable solid cancer that is refractory to or has progressed during or after at least 1 line of appropriate prior systemic anti-cancer therapy, or prior standard of care therapy …
99 years and younger
All genders
This study is a retrospective and prospective medical record review of patients with NSCLC harboring EGFR ex20ins mutations treated at cancer centers participating in ATOMIC.
99 years and younger
All genders
The goal of study 1 and study 2 is to evaluate the effects of ALN-HSD on liver fibrosis and other histologic features of NASH in participants with NASH and F2/F3 fibrosis and risk alleles for HSD17B13. Necessary screening procedures include blood tests, liver stiffness measurement, study-specific genotype criteria, and a …
99 years and younger
All genders
This Phase 1 study will assess the safety, tolerability, and preliminary antileukemic activity of ziftomenib in combination with venetoclax and azacitidine (ven/aza), ven, and 7+3 for two different molecularly-defined arms, NPM1-m and KMT2A-r. We would like to rely on WCG as the IRB of record for this study.
521 - 530 of 930